L&C BIO Co.,LTD (KOSDAQ:290650)
South Korea flag South Korea · Delayed Price · Currency is KRW
53,300
+1,500 (2.90%)
Aug 20, 2026, 3:30 PM KST

L&C BIO Co.,LTD Revenue

L&C BIO Co.,LTD had revenue of 30.29B KRW in the quarter ending March 31, 2026, with 71.44% growth. This brings the company's revenue in the last twelve months to 98.10B, up 34.07% year-over-year. In the year 2025, L&C BIO Co.,LTD had annual revenue of 85.48B with 18.66% growth.

Revenue (ttm)
98.10B
Revenue Growth
+34.07%
P/S Ratio
14.65
Revenue / Employee
570.35M
Employees
172
Market Cap
1.44T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202585.48B13.44B18.66%
Dec 31, 202472.03B6.11B9.26%
Dec 31, 202365.93B13.35B25.40%
Dec 31, 202252.57B6.90B15.10%
Dec 31, 202145.68B12.70B38.53%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
SD Biosensor718.78B
CLASSYS369.10B
Vieworks243.11B
T&L Co., Ltd.157.91B
BioNote126.41B
Dongbang Medical117.37B
Shinhung104.15B
PCL, Inc.4.98B
Revenue Rankings

L&C BIO Co.,LTD News

More News